AU6964001A - Vaccine against the influenza virus and method for producing said virus vaccine - Google Patents
Vaccine against the influenza virus and method for producing said virus vaccineInfo
- Publication number
- AU6964001A AU6964001A AU6964001A AU6964001A AU6964001A AU 6964001 A AU6964001 A AU 6964001A AU 6964001 A AU6964001 A AU 6964001A AU 6964001 A AU6964001 A AU 6964001A AU 6964001 A AU6964001 A AU 6964001A
- Authority
- AU
- Australia
- Prior art keywords
- vaccine
- virus
- producing
- influenza virus
- vaccine against
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/385—Haptens or antigens, bound to carriers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
- A61K39/145—Orthomyxoviridae, e.g. influenza virus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
- A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
- A61K47/56—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule
- A61K47/59—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyureas or polyurethanes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/16—Antivirals for RNA viruses for influenza or rhinoviruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/60—Medicinal preparations containing antigens or antibodies characteristics by the carrier linked to the antigen
- A61K2039/6093—Synthetic polymers, e.g. polyethyleneglycol [PEG], Polymers or copolymers of (D) glutamate and (D) lysine
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
- C12N2760/00011—Details
- C12N2760/16011—Orthomyxoviridae
- C12N2760/16111—Influenzavirus A, i.e. influenza A virus
- C12N2760/16134—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Virology (AREA)
- Epidemiology (AREA)
- Mycology (AREA)
- Immunology (AREA)
- Microbiology (AREA)
- Oncology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Communicable Diseases (AREA)
- Pulmonology (AREA)
- Molecular Biology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Inorganic Chemistry (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Peptides Or Proteins (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
RU2000120902/14A RU2164148C1 (ru) | 2000-08-09 | 2000-08-09 | Вакцина против вируса гриппа и способ ее получения |
PCT/RU2001/000229 WO2002011758A1 (fr) | 2000-08-09 | 2001-06-13 | Vaccin contre le virus de la grippe et procede de fabrication correspondant |
Publications (1)
Publication Number | Publication Date |
---|---|
AU6964001A true AU6964001A (en) | 2002-02-18 |
Family
ID=20238868
Family Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AU2001269640A Ceased AU2001269640B2 (en) | 2000-08-09 | 2001-06-13 | Vaccine against the influenza virus and method for producing said virus vaccine |
AU6964001A Pending AU6964001A (en) | 2000-08-09 | 2001-06-13 | Vaccine against the influenza virus and method for producing said virus vaccine |
Family Applications Before (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AU2001269640A Ceased AU2001269640B2 (en) | 2000-08-09 | 2001-06-13 | Vaccine against the influenza virus and method for producing said virus vaccine |
Country Status (5)
Country | Link |
---|---|
KR (1) | KR100568013B1 (ko) |
CN (1) | CN1464789B (ko) |
AU (2) | AU2001269640B2 (ko) |
RU (1) | RU2164148C1 (ko) |
WO (1) | WO2002011758A1 (ko) |
Families Citing this family (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
RU2428991C9 (ru) | 2010-06-24 | 2011-12-27 | ОБЩЕСТВО С ОГРАНИЧЕННОЙ ОТВЕТСТВЕННОСТЬЮ "НПО Петровакс Фарм" | Сополимеры гетероцепных алифатических поли-n-оксидов, вакцинирующие и лекарственные средства на их основе |
RU2446824C2 (ru) * | 2010-07-20 | 2012-04-10 | Федеральное государственное унитарное предприятие "Научно-производственное объединение по медицинским иммунобиологическим препаратам "Микроген" Министерства здравоохранения и социального развития Российской Федерации | Вакцина против гриппа и способ ее получения |
FI2760882T3 (fi) * | 2011-09-30 | 2023-07-17 | Medicago Inc | Viruksen kaltaisen partikkelin saantojen lisääminen kasveissa |
RU2740751C1 (ru) * | 2019-08-28 | 2021-01-20 | Общество с ограниченной ответственностью "Развитие БиоТехнологий" | Способ получения тетравалентной субъединичной противогриппозной вакцины |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
SU1580617A1 (ru) * | 1988-05-13 | 1997-02-10 | Институт иммунологии | Способ получения вакцины против вируса гриппа |
RU2073031C1 (ru) * | 1990-08-06 | 1997-02-10 | Некрасов Аркадий Васильевич | Производные поли-1,4-этиленпиперазина, обладающие иммуномодулирующей, противовирусной и антибактериальной активностями |
RU2112542C1 (ru) * | 1997-02-28 | 1998-06-10 | Аркадий Васильевич Некрасов | Препарат для лечения патологических состояний соединительной ткани |
RU2153354C1 (ru) * | 1999-03-31 | 2000-07-27 | Московский городской научно-практический центр борьбы с туберкулезом | Вакцина против туберкулеза |
-
2000
- 2000-08-09 RU RU2000120902/14A patent/RU2164148C1/ru active
-
2001
- 2001-06-13 WO PCT/RU2001/000229 patent/WO2002011758A1/ru active IP Right Grant
- 2001-06-13 AU AU2001269640A patent/AU2001269640B2/en not_active Ceased
- 2001-06-13 KR KR1020037001870A patent/KR100568013B1/ko not_active IP Right Cessation
- 2001-06-13 AU AU6964001A patent/AU6964001A/xx active Pending
- 2001-06-13 CN CN018149448A patent/CN1464789B/zh not_active Expired - Fee Related
Also Published As
Publication number | Publication date |
---|---|
AU2001269640B2 (en) | 2005-12-22 |
WO2002011758A8 (fr) | 2003-07-24 |
CN1464789A (zh) | 2003-12-31 |
KR20030059096A (ko) | 2003-07-07 |
RU2164148C1 (ru) | 2001-03-20 |
CN1464789B (zh) | 2010-12-01 |
WO2002011758A1 (fr) | 2002-02-14 |
KR100568013B1 (ko) | 2006-04-05 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EP1708748A4 (en) | INFLUENZA IMMUNOGENS AND VACCINES | |
IL148673A0 (en) | Intranasal influenza virus vaccine | |
EP1309602A4 (en) | MALARIA IMMUNOGEN AND VACCINE | |
GB2337755B (en) | Virus vaccine | |
GB0020953D0 (en) | Vaccine | |
HUP0301092A3 (en) | Vaccine | |
IL155072A0 (en) | Vaccine | |
HK1064958A1 (en) | Vaccine against hpv | |
AU1591402A (en) | Vaccine | |
GB0024200D0 (en) | Component vaccine | |
AU3840101A (en) | Cold-adapted equine influenza viruses | |
IL157609A0 (en) | A vaccine composition and method of using the same | |
GB0014288D0 (en) | Vaccine | |
AU2001278337A1 (en) | Respiratory syncytial virus vaccine | |
AU4472801A (en) | Inactivated japanese B encephalitis vaccine and process for producing the same | |
AU2002212073A1 (en) | A classical swine fever virus epitope vaccine and its producing method | |
AU6964001A (en) | Vaccine against the influenza virus and method for producing said virus vaccine | |
AU2001269640A1 (en) | Vaccine against the influenza virus and method for producing said virus vaccine | |
GB0014845D0 (en) | Vaccine | |
GB0026334D0 (en) | Vaccine | |
AU4957800A (en) | Vaccine against isa virus | |
GB0025694D0 (en) | Vaccine | |
AU2002223398A1 (en) | A vaccine for influenza virus and its preparation | |
GB0003082D0 (en) | Vaccine | |
GB0027433D0 (en) | Vaccine component |